Video

TCT 22: The AMULET-IDE Study: 3-year Outcomes of the Amulet Left Atrial Appendage Occluder in Patients With Atrial Fibrillation

Published: 20 Sep 2022

  • Views:

    Views Icon 58
  • Likes:

    Heart Icon 0

TCT 2022 - Dr Dhanunjaya Lakkireddy (University of Kansas Hospital, Kansas City, US) joins us to discuss the safety and efficacy of the Amulet Left Atrial Appendage Occluder as suggested by the results of the AMULET-IDE Study. 

AMULET-IDE was a prospective, multi-center study with a cohort of 1878 patients with non-valvular atrial fibrillation. Participants were randomized to receive either the Amulet device, or the commercially available WATCHMAN Left Atrial Appendage Closure. The safety and efficacy of the Amulet device was then monitored over a 5-year period. 

Recorded remotely from Kansas City, 2022.
Interviewer: Jordan Rance
Videography: Dan Brent